CDT Equity Stock (NASDAQ:CDT)

Revenue Ownership Financials Chart

Previous Close

$0.60

52W Range

$0.57 - $274.50

50D Avg

$1.74

200D Avg

$32.11

Market Cap

$1.83M

Avg Vol (3M)

$931.52K

Beta

1.90

Div Yield

-

CDT Company Profile

CDT Equity, Inc. engages in facilitating the development and commercialization of clinical assets. The company was founded by David Joszef Tapolczay and Freda C. Lewis-Hall in October 2021 is headquartered in Naples, FL.

Industry

Biotechnology

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

6

IPO Date

Mar 28, 2022

Website

CDT Performance

Revenue Breakdown

Revenue Breakdown by Product/Service

Product/Service	Dec 24
Automation Solutions	$1.32B

Fiscal year ends in Dec 24 | Currency in USD

CDT Financial Summary

	Dec 24	Dec 23	Dec 22
Revenue	$2.46B	-	-
Operating Income	$266.46M	$-5.56M	$-3.16M
Net Income	$198.43M	$-535.00K	$-4.89M
EBITDA	$266.46M	$-324.00K	$-1.43M
Basic EPS	$4.88	$-0.18	$-0.56
Diluted EPS	$4.80	$-0.18	$-0.56

Fiscal year ends in Dec 24 | Currency in USD